Planta Med 2002; 68(7): 596-600
DOI: 10.1055/s-2002-32896
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Inhibition of Telomerase Activity and bcl-2 Expression in Berbamine-Induced Apoptosis in HL-60 Cells

Zhao-Ning Ji1 , Wen-Cai Ye2 , Guo-Qing Liu1 , Yu Huang3
  • 1Department of Pharmacology, China Pharmaceutical University, Nanjing, China
  • 2Department of Phytochemistry, China Pharmaceutical University, Nanjing, China
  • 3Department of Physiology, The Chinese University of Hong Kong, China
Weitere Informationen

Publikationsverlauf

Received: October 22, 2001

Accepted: February 3, 2002

Publikationsdatum:
22. Juli 2002 (online)

Abstract

The present study was aimed to investigate the effect of telomerase activity in berbamine-induced apoptosis and the regulation of B cell leukemia/lymphoma 2 (bcl-2) gene expression in human leukemia HL-60 cells. Apoptosis of HL-60 cells was induced by berbamine (10 μM) for 3, 6, 12 and 24 h. Apoptosis and bcl-2 were determined by flow cytometry analysis. A polymerase chain reaction-based telomeric repeat amplification protocol assay was used to detect the telomerase activity. Berbamine induced growth arrest and apoptotic cell death in HL-60 cells. The telomerase activity was inhibited in a time-dependent manner during the berbamine-induced apoptosis of HL-60 cells, and the expression of bcl-2 was progressively down-regulated by berbamine. Inhibition of the telomerase activity of HL-60 cells was closely related to the berbamine-induced apoptosis. The present results indicate that inhibition of telomerase and reduced bcl-2 gene expression may play a role in the berbamine-induced apoptosis of HL-60 cells.

References

  • 1 Kim N W, Piatyszek M A, Prowse K R, Harley C B, West M D, Ho P L. et al . Specific association of human telomerase activity with immortal cell and cancer.  Science. 1994;  266 2011-5
  • 2 Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar A F . et al . Telomerase activity in human breast tumor.  Journal of National Cancer Institute. 1996;  88 116-22
  • 3 Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna B P, Cowell J K. Inhibition of telomerase increase the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.  Oncogene . 1998;  16 2243-8
  • 4 Mandal M, Kumar R. Bcl-2 modulates telomerase activity.  J Biological Chemistry . 1997;  272 14 183-7
  • 5 Fu W M, Begley J G, Killen M W, Mattson M P. Anti-apoptotic role of telomerase in pheochromocytoma cells.  J Biological Chemistry. 1999;  274 7264-71
  • 6 Zhang W. Mechanism of the protective effects of berbamine on ischemia-reperfusion injury in isolated rat heart.  Zhonghua Xin Xue Guan Bing Za Zhi . 1993;  5 300-3
  • 7 Alley M C, Scudiero D A, Monks A, Hursey M L, Czerwinski M J, Fine D L . et al . Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.  Cancer Research. 1988;  48 589-601
  • 8 Darzynkiewicz Z, Bino S BG, Gorczyca W. Features of apoptotic cells measured by flow cytometry.  Cytometry . 1992;  13 795-9
  • 9 Aiello A, Delia D, Borrello M G, Biassoni D, Giardini R, Fontanella E. et al . Flow cytometric detection of the mitochondrial Bcl-2 protein in normal and neoplastic human lymphoid cells.  Cytometry . 1992;  13 502-9
  • 10 Kim N W, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).  Nucleus Acids Research. 1997;  25 2595-7
  • 11 Herbert B S, Pitts A E, Baker S I, Hamilton S E, Wright W E, Shay J W. et al . Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.  Proceedings of National Academy of Sciences USA. 1999;  96 14 276-81
  • 12 Bestilny L J, Brown C B, Miura Y, Robertson L D, Riabowol K T. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.  Cancer Research. 1996;  56 3796-802
  • 13 Savoysky E, Yoshiida K, Ohtomo T, Yamaguchi Y, Akamatsu K I, Yamazaki T. et al . Down-regulation of telomerase activity id an early event in the differentiation of HL-60 cells.  Biochemical and Biophysical Research Communications. 1996;  226 329-34

Prof. Guo-Qing Liu

Department of Pharmacology

China Pharmaceutical University

Nanjing 210009,
People’s Republic of China

Fax: +86-25-3271340

eMail: liugq@mailbox.cpu.edu.cn